🔎 Trials Near Me

Home › Leucemia mieloide acuta › Missouri › Kansas City

Studi clinici su Leucemia mieloide acuta a Kansas City, MO

15 studi su Leucemia mieloide acuta cercano partecipanti presso sedi a Kansas City e dintorni (entro circa 30 miglia). Apri uno studio per vedere chi può partecipare e come contattare il team.

Testo ufficiale dello studio (inglese)

Stai reclutando per uno studio? Mettilo in evidenza in cima alla pagina — $99 per 30 giorni →

Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)

In reclutamentoFase 2
  • University of Kansas Hospital-Westwood Cancer Center, Westwood · a 5 mi di distanza
Età da 18 a 59 · Tutti i sessi · Aggiornato il 6 ott 2026 · NCT05554406

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

In reclutamentoFase 2
  • University Health Truman Medical Center, Kansas City
  • University of Kansas Cancer Center - Briarcliff, Kansas City
  • University of Kansas Cancer Center - North, Kansas City
  • e altri 1
Età 18 e oltre · Tutti i sessi · Aggiornato il 6 ott 2026 · NCT05564390

Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)

In reclutamentoFase 2
  • University of Kansas Hospital-Westwood Cancer Center, Westwood · a 5 mi di distanza
Età 18 e oltre · Tutti i sessi · Aggiornato il 6 ott 2026 · NCT06317649

Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)

In reclutamentoFase 2
  • University of Kansas Hospital-Westwood Cancer Center, Westwood · a 5 mi di distanza
Età da 18 a 59 · Tutti i sessi · Aggiornato il 6 ott 2026 · NCT05554393

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

In reclutamentoStudio osservazionaleVolontari sani benvenuti
  • Kansas City Veterans Affairs Medical Center, Kansas City
Età da 40 a 75 · Tutti i sessi · Aggiornato il 2 ott 2026 · NCT05334069

Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)

In reclutamentoFase 2
  • University of Kansas Hospital-Westwood Cancer Center, Westwood · a 5 mi di distanza
Età 18 e oltre · Tutti i sessi · Aggiornato il 22 set 2026 · NCT06672146

A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations

In reclutamentoFase 3
  • Children's Mercy Hospitals and Clinics, Kansas City
6 Months – 21 Years · Tutti i sessi · Aggiornato il 17 set 2026 · NCT04293562

A Phase 1b Study of Menin Inhibitor SNDX- 5613 in Combination With Daunorubicin and Cytarabine in Newly Diagnosed Patients With Acute Myeloid Leukemia and NPM1 Mutated/FLT3 Wildtype or MLL/KMT2A Rearranged or NUP98 Alterations Disease

In reclutamentoFase 1
  • University of Kansas Hospital-Westwood Cancer Center, Westwood · a 5 mi di distanza
Età da 18 a 75 · Tutti i sessi · Aggiornato il 25 ago 2026 · NCT05886049

Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)

In reclutamentoFase 3
  • The Children's Mercy Hospital - Adele Hall Campus, Kansas City
29 Days – 21 Years · Tutti i sessi · Aggiornato il 24 ago 2026 · NCT05183035

Study of Revumenib, Azacitidine, and Venetoclax in Pediatric and Young Adult Patients With Refractory or Relapsed Acute Myeloid Leukemia

In reclutamentoFase 1
  • Children's Mercy Hospital of Kansas City, Kansas City
Età da 1 a 30 · Tutti i sessi · Aggiornato il 3 ago 2026 · NCT06177067

Mocravimod as Adjunctive and Maintenance Treatment in AML Patients Undergoing Allo-HCT

In reclutamentoFase 3
  • University of Kansas Cancer Center, Westwood · a 5 mi di distanza
Età da 18 a 75 · Tutti i sessi · Aggiornato il 17 lug 2026 · NCT05429632

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

In reclutamentoStudio osservazionale
  • Children's Mercy Hospital and Clinics, Kansas City
  • University of Kansas, Westwood · a 5 mi di distanza
Tutte le età · Tutti i sessi · Aggiornato il 6 lug 2026 · NCT01351545

Expanded/Activated Gamma Delta T-cell Infusion Following Hematopoietic Stem Cell Transplantation and Post-transplant Cyclophosphamide

In reclutamentoFase 1
  • University of Kansas Cancer Center, Westwood · a 5 mi di distanza
Età da 18 a 65 · Tutti i sessi · Aggiornato il 25 mar 2026 · NCT03533816

A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation

In reclutamentoFase 2
  • University of Kansas Medical Center, Westwood · a 5 mi di distanza
Età da 18 a 66 · Tutti i sessi · Aggiornato il 17 mar 2026 · NCT06859424

Studi su Leucemia mieloide acuta in altre città

Altri studi a Kansas City

Fonte: ClinicalTrials.gov, dati recuperati il 7 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.